OnCore Login

Return to Trial Database

HCRN-GU22-595

EXACT: Randomized phase II trial of XL092 in combination with immunotherapy in patients who progress on Adjuvant therapy in Clear Cell RCC

Status

Currently Enrolling

Cancer Type(s)

Kidney

Study Contact

(317) 921-2050
studies@hoosiercancer.org

Trial Locations

All sites in which the trial HCRN-GU22-595 being conducted in.
Columbia University Irving Medical Center
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278